Vaccinex, Inc. (NASDAQ:VCNX – Get Free Report)’s share price rose 1.4% on Thursday . The stock traded as high as $0.6995 and last traded at $0.6995. Approximately 564 shares were traded during trading, a decline of 79% from the average daily volume of 2,738 shares. The stock had previously closed at $0.6899.
Vaccinex Trading Up 1.4%
The firm has a market capitalization of $1.82 million, a P/E ratio of -0.01 and a beta of 1.10. The stock’s 50-day simple moving average is $0.62 and its 200-day simple moving average is $0.69.
Vaccinex Company Profile
Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.
Featured Articles
- Five stocks we like better than Vaccinex
- Growth Stocks: What They Are, What They Are Not
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- How to Effectively Use the MarketBeat Ratings Screener
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- What is a Bond Market Holiday? How to Invest and Trade
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Vaccinex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccinex and related companies with MarketBeat.com's FREE daily email newsletter.
